Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Shareholders' Equity (Unaudited)

v3.19.1
Consolidated Statements Of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock and Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2017 $ 29,260 $ 225,012 $ (576) $ (195,176)
Issuance of common stock upon exercise of options   2    
Stock offering costs   (38)    
Stock-based compensation expense   650    
Other comprehensive (loss) income     84  
Net loss (5,021)     (5,021)
Ending balance at Mar. 31, 2018 24,937 225,626 (492) (200,197)
Beginning balance at Dec. 31, 2018 11,089 228,451 (670) (216,692)
Issuance of common stock upon exercise of options   3    
Settlement of liability awards   202    
Stock-based compensation expense   634    
Other comprehensive (loss) income     (55)  
Net loss (4,900)     (4,900)
Ending balance at Mar. 31, 2019 $ 6,973 $ 229,290 $ (725) $ (221,592)